Diagnostic Imaging Devices are used for the visualization of structural and functional patterns of organs or tissues. Mammography equipment is a type of medical imaging equipment that uses X-rays to capture images (mammograms) of the internal structures of the breasts. GlobalData uses proprietary data and analytics to provide a comprehensive report on the mammography equipment devices market, including market shares of different players within Poland. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the mammography equipment market in Poland was GE Healthcare Technologies followed by Hologic, Siemens Healthineers, Philips Healthcare Informatics and Fujifilm.
Mammography plays a key role in early diagnosis of breast cancer. 2D Digital Mammography Equipment, Breast Tomosynthesis and Retrofit Breast Tomosynthesis are covered in this category. Tracked here are the equipment only and not accessories and/or additional costs associated with Mammography Equipment installation. In 2D Digital Mammography Equipment, X-ray beams are captured on the digital camera and images are produced by the computer, and that images are sent electronically to the radiologists to view. Breast Tomosynthesis is a system in which the imaging machines moves around the breast in an arc and taking multiple X-rays that is converted by the computer into 3D images. Retrofit Breast Tomosynthesis systems are digital panel detectors that enable the upgrade of 2D Digital Mammography Equipment to 3D Digital Mammography Equipment by retrofitting rotating gantry DBT (Digital Breast Tomosynthesis) scanner with a spatially distributed CNT (Carbon Nanotube) X-ray source array.
The value of the mammography equipment devices market within Poland was expected to be over $10m in 2023.
For the latest complete market share analysis of mammography equipment device market in Poland, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
